Sublingual Methadone for the Management of Cancer-related Procedure Pain in Inpatients
NCT00351637
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
60
Enrollment
OTHER
Sponsor class
Stopped
Study suspended due to low accrual
Conditions
Cancer
Pain
Interventions
DRUG:
Sublingual Methadone
Sponsor
Alberta Health services